Novel method and compounds for treatment of cognitive loss associated with adult onset leukodystrophy with axonal spheroids and pigmented glia (alsp) and other neurodegenerative diseases involving reduced colony stimulating factor-1 receptor (csf-1r) signaling
WO2019236875A1
Antibodies or antibody-fragments thereof targeting alphaviruses, and compositions and methods comprising same
WO2019126112A1
Combined markers for metastatic cancer and uses thereof
WO2019108492A1
Prevention and treatment of viral infections
WO2019079243A1
Mitofusin activators and uses thereof
US2019185547A1
Filovirus antibody
WO2018222644A1
Method for treating neoadjuvant chemotherapy-induced metastasis
WO2018195254A1
RNA TAGGING SYSTEM FOR VISUALIZATION OF SINGLE mRNA MOLECULES
WO2018187190A1
Precision activation of hiv-specific ctls to eliminate reactived latent t cells
WO2018156464A1
Characterization of s-adenosyl-l-methionine-consuming enzymes with 1-step ez-mtase: a universal coupled-assay
US2018239878A1
Dna methyltransferase 1 transition state structure and uses thereof
CA3053147A1
Sol-gel/hydrogel therapeutic delivery system and methods thereof
WO2018136575A1
Pxr agonists and uses thereof for gut barrier dysfunction treatment and prevention
WO2018106579A1
Drug targeting of human indoleamine 2,3-dioxygenase
US2018074049A1
Methods and compositions for rapid functional analysis of gene variants
WO2018075264A1
Chemically modified rna aptamers and uses thereof
WO2018039100A2
Stem cell-produced microvesicles for treating tendon pathologies
WO2017223260A1
Pu.1 inhibitors
WO2017205560A1
Methods for treating cancer by targeting vcam1 and maea
CN109689096A
Variant PD-L1 polypeptide, T cell modulability multimeric polypeptide and its application method
